Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer Jamunarani Veeraraghavan , Carolina Gutierrez , Carmine De Angelis , Robert Davis , Tao Wang , Tomas Pascual , Pier Selenica , Katherine Sanchez , Hiroaki Nitta , Monesh Kapadia , Anne C. Pavlick , Patricia Galvan , Brent Rexer , Andres Forero-Torres , Rita Nanda , Anna M. Storniolo , Ian E. Krop , Matthew P. Goetz , Julie R. Nangia , Antonio C. Wolff , Britta Weigelt , Jorge S. Reis-Filho , Susan G. Hilsenbeck , Aleix Prat , C. Kent Osborne , Rachel Schiff , Mothaffar F. Rimawi crossref(2023)
摘要
Supplementary Figure S1. Study design and tissue availability for biomarker analysis.
更多 查看译文
AI 理解论文
溯源树
样例